tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Ovid Therapeutics Inc

OVID
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
2.220USD
-0.150-6.33%
์ข…๊ฐ€ย 07-31 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
414.34M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

OVID ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Ovid Therapeutics Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

Ovid Therapeutics Inc ์‹ค์  ๋ฐœํ‘œ์ผ

์ตœ์‹  ์ถœ์‹œ
May 12, 2026
EPS / ์˜ˆ์ƒ
-0.12/-0.12
์ˆ˜์ต / ์˜ˆ์ƒ
0.00/32.50K
์ฃผ๊ธฐ
FY2025 ์žฌ๋ฌด์ œํ‘œ
์ˆ˜์ต(YoY)
7.25M
1181.27%
EPS(YoY)
-0.24
36.65%
์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€
STRONG BUY
2026/08/02
๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
YOY
๋นˆ ํ–‰ ์ˆจ๊ธฐ๊ธฐ
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
์žฌ๋ฌด ์ง€ํ‘œ
EPS
13.40%-0.12
190.80%0.12
13.36%-0.17
-154.82%-0.07
12.88%-0.14
39.88%-0.13
-23.84%-0.20
168.30%0.12
12.72%-0.17
-32.77%-0.22
---0.16
---0.18
---0.19
---0.16
---0.61
----
----
----
----
----
์ˆ˜์ต
-100.00%0.00
844.74%718.00K
-23.70%132.00K
3611.24%6.27M
-12.16%130.00K
-46.31%76.00K
58.76%173.00K
125.33%169.00K
123.70%148.00K
205.88%141.56K
881.55%108.97K
--75.00K
-95.42%66.16K
--46.28K
--11.10K
--0.00
-99.31%1.45M
-100.00%0.00
-100.00%0.00
--0.00
์ˆœ์ด์ต
-65.98%-16.99M
204.43%9.66M
13.19%-12.16M
-154.97%-4.68M
12.48%-10.23M
39.61%-9.25M
-24.47%-14.01M
168.67%8.52M
12.45%-11.69M
-33.18%-15.32M
5.98%-11.25M
14.94%-12.41M
17.08%-13.36M
54.26%-11.50M
-5.13%-11.97M
7.60%-14.59M
-109.56%-16.11M
-14.17%-25.15M
30.69%-11.38M
29.99%-15.79M
์ˆœ์ด์ต๋ฅ 
----
111.05%1345.82%
-13.77%-9210.61%
-101.48%-74.68%
0.36%-7873.08%
-12.49%-12175.00%
21.60%-8095.95%
130.48%5042.01%
60.86%-7901.35%
56.46%-10823.47%
---10325.94%
---16544.44%
---20187.74%
---24859.09%
---2929.29%
----
----
----
----
----
์ด ์ด์ต๋ฅ 
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
์ˆ˜์ต
-100.00%0.00
844.74%718.00K
-23.70%132.00K
3611.24%6.27M
-12.16%130.00K
-46.31%76.00K
58.76%173.00K
125.33%169.00K
123.70%148.00K
205.88%141.56K
881.55%108.97K
--75.00K
-95.42%66.16K
--46.28K
--11.10K
--0.00
-99.31%1.45M
-100.00%0.00
-100.00%0.00
--0.00
์˜์—… ์ด์ต
-42.20%-17.85M
-14.65%-12.29M
5.32%-12.52M
75.27%-5.07M
27.94%-12.55M
41.05%-10.72M
-9.95%-13.23M
-44.77%-20.52M
-16.95%-17.42M
-49.42%-18.19M
6.05%-12.03M
0.92%-14.17M
8.45%-14.89M
53.81%-12.17M
-9.61%-12.80M
0.06%-14.30M
-109.21%-16.27M
-22.06%-26.35M
28.79%-11.68M
38.15%-14.31M
์ˆœ์ด์ต
-65.98%-16.99M
204.43%9.66M
13.19%-12.16M
-154.97%-4.68M
12.48%-10.23M
39.61%-9.25M
-24.47%-14.01M
168.67%8.52M
12.45%-11.69M
-33.18%-15.32M
5.98%-11.25M
14.94%-12.41M
17.08%-13.36M
54.26%-11.50M
-5.13%-11.97M
7.60%-14.59M
-109.56%-16.11M
-14.17%-25.15M
30.69%-11.38M
29.99%-15.79M
์œ ๋™์ž์‚ฐ
248.74%160.15M
32.94%74.37M
-56.21%28.82M
-47.97%42.09M
-50.71%45.92M
-48.96%55.94M
-28.23%65.83M
-20.83%80.89M
-22.05%93.17M
-16.58%109.60M
-34.72%91.71M
-34.54%102.17M
-29.73%119.52M
-31.03%131.38M
-31.48%140.50M
-27.70%156.08M
-28.13%170.09M
154.50%190.48M
126.97%205.06M
389.39%215.87M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
69.21%15.75M
-21.23%8.29M
-41.56%6.80M
-36.79%8.92M
4.54%9.31M
-8.30%10.52M
34.24%11.63M
39.22%14.12M
32.47%8.90M
64.12%11.47M
28.68%8.66M
10.05%10.14M
-34.29%6.72M
-52.75%6.99M
-33.11%6.73M
-18.37%9.22M
-37.43%10.23M
-32.93%14.80M
-43.96%10.06M
-22.60%11.29M
์ด ์ž์‚ฐ
176.32%225.63M
63.76%150.93M
-37.80%63.85M
-34.43%77.43M
-37.96%81.65M
-36.01%92.17M
-17.90%102.65M
-13.31%118.09M
-8.20%131.61M
-7.24%144.03M
-24.24%125.03M
-23.18%136.23M
-24.98%143.37M
-20.19%155.27M
-20.31%165.03M
-18.66%177.33M
-19.52%191.10M
156.23%194.54M
126.08%207.09M
380.65%218.00M
๋ถ€์ฑ„ ์ด๊ณ„
22.26%27.36M
-15.32%20.27M
-27.36%19.15M
-25.87%21.64M
-58.04%22.38M
-57.42%23.94M
11.07%26.36M
14.33%29.19M
137.89%53.33M
144.55%56.23M
3.29%23.74M
1.38%25.53M
-14.10%22.42M
55.38%22.99M
128.34%22.98M
123.05%25.18M
59.67%26.10M
-54.18%14.80M
-64.00%10.06M
-24.09%11.29M
์ž๋ณธ ์ด๊ณ„
234.48%198.27M
91.51%130.66M
-41.41%44.70M
-37.25%55.79M
-24.28%59.28M
-22.29%68.23M
-24.68%76.29M
-19.69%88.90M
-35.28%78.28M
-33.62%87.80M
-28.69%101.29M
-27.24%110.70M
-26.70%120.95M
-26.41%132.27M
-27.90%142.05M
-26.40%152.15M
-25.38%165.00M
311.96%179.75M
209.57%197.02M
578.12%206.71M
์ˆœ์˜์—…์ด์ต
-35.20%-13.90M
-4.00%-10.41M
14.23%-12.87M
66.51%-4.77M
38.39%-10.28M
15.99%-10.01M
-49.31%-15.01M
-21.79%-14.26M
-37.75%-16.68M
-29.82%-11.91M
20.71%-10.05M
11.91%-11.71M
39.70%-12.11M
23.53%-9.18M
-16.60%-12.68M
31.56%-13.29M
-112.48%-20.09M
17.31%-12.00M
-639.88%-10.87M
-12.93%-19.42M
์ˆœํˆฌ์ž
16.62%5.95M
-438.45%-72.06M
1630.48%5.05M
-6.00%12.05M
-74.73%5.10M
143.89%21.29M
106.70%292.00K
-36.10%12.82M
-33.22%20.19M
-1063.59%-48.52M
-122.38%-4.36M
124.87%20.07M
2908.94%30.23M
-2474.44%-4.17M
-2961.38%-1.96M
-4993.60%-80.68M
-9246.58%-1.08M
-79.00%-161.96K
-67.17%-64.03K
-105.12%-1.58M
์ˆœ์žฌ๋ฌดํ™œ๋™
684376.92%88.98M
--75.18M
-60.53%15.00K
-100.00%0.00
-94.30%13.00K
-100.00%0.00
-83.01%38.00K
68.64%356.00K
240.33%228.00K
68985.51%30.03M
174.07%223.72K
92.70%211.10K
102.52%66.99K
-139.93%-43.60K
-85.13%81.63K
-5.71%109.55K
-74.49%33.08K
146.96%109.18K
-98.83%549.05K
-31.38%116.19K

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Ovid Therapeutics Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ovid Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 7.25M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 566.00K์ž…๋‹ˆ๋‹ค.

Ovid Therapeutics Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ovid Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 74.37M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 32.94์ž…๋‹ˆ๋‹ค.

Ovid Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ovid Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ovid Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ 150.93M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 63.76์ž…๋‹ˆ๋‹ค.

Ovid Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ovid Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ovid Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” 20.27M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -15.32์ž…๋‹ˆ๋‹ค.

Ovid Therapeutics Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ovid Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ovid Therapeutics Inc์˜ ์ด์ž๋ณธ์€ 130.66M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 91.51์ž…๋‹ˆ๋‹ค.

Ovid Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ovid Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ovid Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -42.44M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 31.42์ž…๋‹ˆ๋‹ค.

Ovid Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ovid Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ovid Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” -49.85M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -191.32์ž…๋‹ˆ๋‹ค.

Ovid Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ovid Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ovid Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 75.21M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 11991.16์ž…๋‹ˆ๋‹ค.

Ovid Therapeutics Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ovid Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -0.24์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 36.65์ž…๋‹ˆ๋‹ค.

Ovid Therapeutics Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ovid Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -17.41M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 34.12์ž…๋‹ˆ๋‹ค.

Ovid Therapeutics Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ovid Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ -240.13์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 94.86์ž…๋‹ˆ๋‹ค.

Ovid Therapeutics Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ovid Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -17.51์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 48.32์ž…๋‹ˆ๋‹ค.

Ovid Therapeutics Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ovid Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -14.33์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 35.99์ž…๋‹ˆ๋‹ค.

Ovid Therapeutics Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ovid Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -42.44M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 31.42์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ